𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti–apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis

✍ Scribed by Nicolas Vuilleumier; Sylvette Bas; Sabrina Pagano; Fabrizio Montecucco; Pierre-André Guerne; Axel Finckh; Christian Lovis; François Mach; Denis Hochstrasser; Pascale Roux-Lombard; Cem Gabay

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
188 KB
Volume
62
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA–DRB1 and persistent chronic inflamma
HLA–DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis
✍ Gonzalez-Gay, Miguel A. ;Gonzalez-Juanatey, Carlos ;Lopez-Diaz, Maria J. ;Piñeir 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## Abstract ## Objective Cardiovascular (CV) disease is the most common cause of mortality in patients with rheumatoid arthritis (RA). We assessed the contribution of epidemiologic features, clinical features, routine laboratory markers of inflammation, and HLA–DRB1 alleles to CV mortality in pati

A randomized controlled trial with an an
A randomized controlled trial with an anti-CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
✍ Jasper J. Haringman; Danielle M. Gerlag; Tom J. M. Smeets; Dominique Baeten; Fil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract ## Objective Chemokines such as CCL2/monocyte chemotactic protein 1 (MCP‐1) play a key role in leukocyte migration and are potential targets in the treatment of chronic inflammatory disorders. The objective of this study was to evaluate the effects of human anti–CCL2/MCP‐1 monoclonal a